{
    "Trade/Device Name(s)": [
        "OnTrak TesTcard"
    ],
    "Submitter Information": "Varian, Inc.",
    "510(k) Number": "K051235",
    "Predicate Device Reference 510(k) Number(s)": [
        "K012396",
        "K050321"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "DIO",
        "DJJ",
        "LCM",
        "LDJ",
        "LAF",
        "LFG"
    ],
    "Summary Letter Date": "June 8, 2005",
    "Summary Letter Received Date": "May 13, 2005",
    "Submission Date": "May 11, 2005",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3640",
        "21CFR862.3870",
        "21CFR862.3610",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine test system",
        "Morphine test system",
        "Cannabinoids test system",
        "Methamphetamine test system",
        "Tricyclic Antidepressant Drugs test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cocaine metabolite",
        "Methamphetamine",
        "Morphine",
        "Phencyclidine",
        "Tricyclic Antidepressants",
        "THC"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Microparticle capture inhibition"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for OnTrak TesTcard qualitative urine drugs of abuse screening device using microparticle capture inhibition technology.",
    "Indications for Use Summary": "Qualitative in vitro detection of multiple drugs and drug metabolites in urine using different panels, providing preliminary results requiring confirmatory testing.",
    "fda_folder": "Toxicology"
}